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Ready for Take-Off?*Ashvin N. Pande, MD, Alice K. Jacobs, MDSEE PAGE 363T he ﬁrst nonstop transatlantic crossingoccurred in 1919, in a World War I–era twin-engine biplane ﬂown by British aviators
from St. John’s, Newfoundland, to Galway, Ireland,
in over 16 h (1), launching an era of long-distance air
travel. In 1953, given the unreliability of early
airplane engines, aviation authorities restricted 2-
engine airplanes to routes within short range of
“diversion” airports where a disabled plane could
ﬂy to safety (2). As engine reliability improved and
engine failure became increasingly rare, these pre-
cautions seemed outdated. In 1985, the U.S. Federal
Aviation Administration developed a program that
included rigorous maintenance and operational pro-
cedures to certify twin-engine jets to ﬂy extended-
range journeys (3). This opened more direct air routes
to smaller, more efﬁcient planes and expanded
access to nonstop routes worldwide (3).
Similarly, percutaneous coronary intervention
(PCI), ﬁrst introduced nearly 4 decades ago by
pioneer Andreas Grüntzig (4), launched dramatic
growth in coronary revascularization. Initially limited
to balloon angioplasty of proximal stenoses in large
vessels, with an operating room and cardiothoracic
surgeon on standby in case of procedural complica-
tion requiring emergency coronary artery bypass
surgery (CABG), PCI has evolved to include mul-
tiple devices in the treatment of complex coronary
anatomy. The advent of stents and improvements
in device technology, procedural technique, and*Editorials published in the Journal of the American College of Cardiology
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paper to disclose.adjunctive pharmacotherapy, as well as increased
operator experience, have reduced the incidence of
emergency CABG after PCI from a range of 6% to 10%
to a range of 0.1% to 0.3% (5–7). As a result, coupled
with the mandate for improved access to prompt
primary PCI for acute ST-segment elevation myocar-
dial infarction (STEMI), the cardiovascular commu-
nity has seen the growth of facilities that perform PCI
without onsite cardiac surgery. Of all reporting facil-
ities performing PCI in the United States in 2004,
8.7% did not have onsite cardiac surgery compared
with 32.6% in 2011, with a corresponding rise in the
proportion of PCI procedures performed in these fa-
cilities, from 3.9% of total PCI procedures reported in
2005 to 12.4% in 2011 (5,8). Both in the United States
and in the United Kingdom, these numbers continue
to rise. Randomized controlled trials examining the
safety of this practice for nonemergency PCI have
reported noninferiority of procedures performed
at sites without compared with those with onsite
cardiac surgical services with respect to short- and
intermediate-term outcomes (9,10).In this issue of the Journal, Garg et al. (11) report the
results of a retrospective analysis of outcomes of
384,013 PCI procedures tracked by the national British
Cardiovascular Intervention Society database be-
tween 2006 and 2012, of which 119,096 (31%) were
performed in hospitals with offsite surgical support.
Patients undergoing PCI at centers with offsite surgi-
cal support were older, with a higher prevalence
of female sex, prior revascularization, peripheral
vascular disease, and left ventricular dysfunction,
whereas patients treated at centers with onsite sur-
gical support were more likely to undergo PCI for
STEMI, multivessel disease, and bypass graft lesions,
as well as PCI with circulatory support, and to undergo
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374emergency CABG. The primary endpoint of the study,
all-cause mortality rate at 30 days, was lower in pa-
tients treated in centers with offsite compared with
onsite surgical support (2.0% vs. 2.2%; p < 0.001),
although unadjusted Kaplan-Meier survival curves
revealed increased survival for patients with stable
angina and decreased survival for patients with non-
STEMI and STEMI at centers with offsite surgical
support. Multivariable adjustment performed to ac-
count for confounders revealed no difference in haz-
ard ratios for mortality between groups at 30 days and
1 and 5 years, irrespective of procedural indication,
and these comparable survival rates were conﬁrmed
in a sensitivity analysis of a propensity-matched
cohort of 74,001 patients. The authors concluded
that PCI performed at centers without onsite surgical
support is not associated with a mortality hazard.
Although not randomized, this study contributes a
large dataset that consists of a mandated national
registry that compares patients arriving and being
treated at both centers with and without onsite car-
diac surgery. In reality, a trial designed to best answer
the question, one that randomizes patients on arrival
at centers both with and without onsite cardiac sur-
gery to PCI at centers both with and without onsite
cardiac surgery, is very unlikely to be performed. Of
note, the randomized trials compared a strategy of
the transfer of patients for PCI to a hospital with onsite
surgical support to that of the performance of PCI
at the initial hospital without onsite support (9,10).
Several caveats inherent to the nature of the study
and limitations of the database are noteworthy. First,
results are limited to mortality (albeit, arguably most
important). Other outcomes, including complete or
repeat revascularization and incidence of transfer
from offsite to onsite cardiac surgery facilities, as well
as the incidence of complications such as recurrent
myocardial infarction, stroke, or bleeding, are un-
available. These nonfatal endpoints are of interest
when one considers the effectiveness and safety of a
new practice pattern. Second, the randomized trials
speciﬁed rigorous pathways and standards for PCI
program development, including mandated staff
training, operator certiﬁcation, quality management,
and PCI volume requirements for institutions plan-
ning PCI without onsite cardiac surgery. The current
study, retrospective in character, does not engage in
the question of program development for expansion
of PCI.
Notwithstanding the above concerns, these data
add to a growing body of evidence that suggests that
PCI procedures performed at facilities without versus
those with onsite cardiac surgery are comparable in
safety. Yet several issues will still need ongoingthoughtful consideration. Atomization of PCI volume
and experience, with a growing number of procedures
being performed at an increasing number of low-
volume centers, remains a concern (5). Given the as-
sociation of PCI volume and outcomes, monitoring
volumes and performance in the midst of this growth
is in the public interest (12–14). Interestingly, data
presented by Garg et al. (11) indicate that the growth
of the centers without onsite cardiac surgery did not
come at the expense of centers with onsite surgical
support; the onsite centers maintained stable vol-
umes, while the offsite centers continued to grow.
These ﬁndings may reﬂect system-speciﬁc features
(e.g., new centers serving underserved areas and
a national health system with long wait times for
procedures) not reproducible in the United States,
where cannibalization of volume within a region has
the potential to threaten both quality and fellow
training (as PCI procedures move away from full-
service centers with approved training programs).
Moreover, in an increasingly cost-conscious envi-
ronment, expanded PCI programs will likely need to
demonstrate additional access to care and procedural
appropriateness and not mere duplication of services.
Additionally, the beneﬁts of onsite cardiac surgery
go beyond the proximity of the operating theater.
Rather, they also imply the presence of an interdisci-
plinary “heart team,” as recommended by revascular-
ization guidelines (15–17). At its best, such a teamworks
together to determine the ideal approach for patients
with complex coronary disease and may offer patients
the fullest range of options. Although current com-
munication technology may allow for an improvised
virtual heart team, it is unclear whether PCI facilities
without onsite cardiac surgery can incorporate surgical
counsel from partnering institutions and provide a
comparable experience for optimal patient care.
When faced with changes in the practice of medi-
cine, like aviation, we generally favor conservative
approaches. Safety is paramount, and the medical
community is reluctant to withdraw a safety net until
a compelling new paradigm of need and safety can
be put in its place. Gathering evidence has leaned
opinion in the cardiovascular community toward
expansion of PCI to facilities without onsite cardiac
surgery, but we must take steps to ensure that this
occurs in the context of appropriate standards and
program development to best serve and protect our
patients.
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